Journal
REGENERATIVE THERAPY
Volume 10, Issue -, Pages 127-133Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.reth.2019.03.002
Keywords
Decellularized liver; Recellularization; Human iPSC; Hepatocyte; Artificial liver
Categories
Funding
- Japan Society for the Promotion of Science [16H05489]
- Grants-in-Aid for Scientific Research [16H05489] Funding Source: KAKEN
Ask authors/readers for more resources
Introduction: Liver transplantation is currently the only curative therapy for end-stage liver failure; however, establishment of alternative treatments is required owing to the serious donor organ shortage. Here, we propose a novel model of hybrid three-dimensional artificial livers using both human induced pluripotent stem cells (hiPSCs) and a rat decellularized liver serving as a scaffold. Methods: Rat liver harvesting and decellularization were performed as reported in our previous studies. The decellularized liver scaffold was recellularized with hiPSC-derived hepatocyte-like cells (hiPSC-HLCs) through the biliary duct. The recellularized liver graft was continuously perfused with the culture medium using a pump at a flow rate of 0.5 mL/min in a standard CO 2 (5%) cell incubator at 37 degrees C. Results: After 48 h of continuous perfusion culture, the hiPSC-HLCs of the recellularized liver distributed into the parenchymal space. Furthermore, the recellularized liver expressed the albumin (ALB) and CYP3A4 genes, and secreted human ALB into the culture medium. Conclusion: Novel hybrid artificial livers using hiPSCs and rat decellularized liver scaffolds were successfully generated, which possessed human hepatic functions. (C) 2019, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available